Anti-Human CFTR Monoclonal Antibody (1A508) from ProteoGenix; catalogue ARO-A23276; research use only.
Know who made it. See the evidence. Buy through one marketplace.
The Anti-Human CFTR Monoclonal Antibody (1A508) is a highly specific and potent antibody designed for use in biotech research. This antibody targets the human Cystic Fibrosis Transmembrane Conductance Regulator (CFTR), a protein that plays a crucial role in regulating the movement of ions across cell membranes.
The biological function of the Anti-Human CFTR Monoclonal Antibody (1A508) is to detect and bind to the CFTR protein, allowing for the study of its expression, localization, and function in various cellular processes. This antibody is ideal for researchers looking to understand the role of CFTR in diseases such as cystic fibrosis, as well as its potential as a therapeutic target.
The main applications of the Anti-Human CFTR Monoclonal Antibody (1A508) include Western blotting, immunofluorescence, and immunohistochemistry. It has been extensively validated for use in these techniques, ensuring reliable and reproducible results. Additionally, this antibody is suitable for use in both human and animal samples, making it a versatile tool for a wide range of research projects.
In terms of experimental use cases, the Anti-Human CFTR Monoclonal Antibody (1A508) has been successfully used in studies investigating CFTR expression in lung tissues, as well as in cell culture models of cystic fibrosis. Its high specificity and sensitivity make it an essential tool for accurately detecting and quantifying CFTR levels in various sample types.
With its and concise structure, the Anti-Human CFTR Monoclonal Antibody (1A508) product description is tailored to meet the needs of scientific SEO writing. By focusing on clarity, relevance, and buyer intent, this description effectively highlights the key features and applications of this powerful biotech research tool. So why wait? Add the Anti-Human CFTR Monoclonal Antibody (1A508) to your research arsenal today and unlock new insights into CFTR biology.
ProteoGenix catalogue number ARO-A23276. For research use only.
Target: Cystic fibrosis transmembrane conductance regulator, CFTR, ATP-binding cassette sub-family C member 7, Channel conductance-controlling ATPase, EC:5.6.1.6, cAMP-dependent chloride channel, CFTR; Clonality: Monoclonal Antibody; Reactivity: Human; Applications: ELISA, IHC.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Species | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA | IHC |
|---|---|---|---|---|---|---|---|---|---|
| Human |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
